Revenue

A new certification for AI-guided cardiac ultrasound seeks to solve the training and trust gap, making crucial heart scans more accessible for frontline providers.

After a rare Q4 earnings miss rattled investors, pest control giant Rollins, Inc. sets its Q1 2026 report date. Can the company prove its growth story is intact?

A new commercial terminal at Jacqueline Cochran Regional Airport will blend modern design and history, aiming to transform travel and tourism in the region.

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

As regulations tighten, a new partnership integrates AI automation with sustainability ratings, making ethical sourcing a seamless part of procurement workflows.

A new 176-unit townhome community in Frederick offers a rental-based alternative to homeownership, highlighting a national trend reshaping urban living.

Crux Capital's new partnership with Ivybrook Academy signals a major investment trend in flexible, high-quality early education franchise models.

From knitting injuries to problems with in-laws, medical codes are a costly mess. AI is now untangling the $36 billion problem, one bizarre diagnosis at a time.

The Oklahoma drinkware giant integrates philanthropy into its DNA, pledging $1.8M for 2026 and showcasing a unique model for corporate giving.

With the hire of sales veteran Jamie Shreeves, Eagleview signals its intent to deepen its dominance in the rapidly modernizing P&C insurance technology market.

HCM giant Paylocity buys AI startup Grayscale, signaling a major push to automate high-volume hiring. But can it solve the efficiency puzzle without bias?

Lupin wins FDA approval for its generic dapagliflozin, a move set to slash costs for a blockbuster diabetes and heart drug and reshape patient care.

A new holding company from Rise8's founder offers an alternative to VC, aiming to scale mission-critical software without sacrificing founder autonomy.

US firm SunHydrogen opens a Japan office led by a top researcher, aiming to scale its solar hydrogen tech in one of the world's leading clean energy markets.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

AI firm Pixability adds creator economy authority Jamie Gutfreund to its board, signaling a major push to integrate data, ads, and creators for brands.

As AI drives DRAM costs to a breaking point, one startup's software uses AI to fight back, promising to slash server costs and expand memory capacity.

Following a viral two-hour sellout, Rachel Mansfield's cadootz! has secured over $3M to expand its ultra-clean kids' crackers into major retail.

Miami startup Petwealth emerges from stealth with at-home PCR tests and key partnerships, aiming to revolutionize the $200B pet health industry.

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.